|Bid||0.6500 x 0|
|Ask||0.8000 x 0|
|Day's Range||0.7500 - 0.7500|
|52 Week Range||0.1400 - 0.7500|
|Beta (5Y Monthly)||1.37|
|PE Ratio (TTM)||0.96|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
KIRKLAND, QC , June 30, 2020 /CNW Telbec/ - Manitex Capital Inc. (" Manitex " or the " Company ") announced today that it has filed a restatement of its previously reported financial ...
KIRKLAND, QC, Oct. 10, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex") announces that it has acquired convertible debenture units ("Units") of Ortho Regenerative Technologies Inc. ("Ortho RTI") in consideration of the conversion of loans that were owed by Ortho RTI in its favor for an aggregate principal amount of $894,000. Each Unit consists of one 10% unsecured convertible debenture for a principal amount of $1,000 (each, a "Debenture") convertible at a $0.30 price per Class "A" share of Ortho RTI ("Common Share") and 2,000 Common Share purchase warrants (each, a "Warrant"), with an exercise price of $0.50 ("Exercise Price"), representing a 60% warrant coverage.
KIRKLAND, QC, Aug. 28, 2019 /CNW Telbec/ - Manitex Capital Inc. ("Manitex") is pleased to announce that it has completed the distribution to its shareholders of its previously announced special dividend-in-kind (the "Dividend") of share purchase warrants of Valeo Pharma Inc., ("Valeo Warrants") held by Manitex. The Dividend has a deemed price of $0.065 per Valeo Warrant and was distributed today to holders of record of common shares of Manitex ("Manitex Shares") at the close of business on August 9, 2019 (the "Record Date"), on a pro rata basis of 0.1 Valeo Warrant per Manitex Share.